15.49 -0.19 (-1.21%)
MAPP
| Trade MAPP now with |
|
Stock Details
Last Trade:15.49 Change:-0.19 (-1.21%) Prev Close:15.68 Open: 15.70 Days Range:15.44 – 15.80 52 Week Range: 10.54 - 17.35 Volume:88050 P/E: 91.12EPS:0.17
View AllRecent Alerts 02/09/12
Recent Alert on 01/17/12 at 10:43am
Canaccord Genuity on Specialty Pharma: 5 Themes for 2012; 4 Best Stock Ideas
Canaccord Genuity on Specialty Pharma: 5 Themes for 2012; 4 Best Stock Ideas
Canaccord Genuity on Specialty Pharma: 5 Themes for 2012; 4 Best Stock Ideas Analyst Randall Stanicky called out five themes that will impact the specialty pharmaceutical sector: 1) FDA changes this year (GDUFA, biologic pathway); 2)... Read More
Recent Alert on 01/05/12 at 12:09pm
Streetinsider.com's Hot Lunchtime Reads 01/05: (STX) (LEAP)/(PCS) (DNDN) (AAPL) (NFLX)
Streetinsider.com's Hot Lunchtime Reads 01/05: (STX) (LEAP)/(PCS) (DNDN) (AAPL) (NFLX)
Recent Alert on 01/05/12 at 11:01am
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Three Small-Cap Buy Ideas for 2012
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Three Small-Cap Buy Ideas for 2012
Recent Alert on 01/05/12 at 11:01am
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Three Small-Cap Buy Ideas for 2012
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Three Small-Cap Buy Ideas for 2012
Recent Alert on 01/05/12 at 8:22am
UPDATE - Canaccord Genuity Initiates Coverage on MAP Pharmaceuticals (MAPP) with a Buy; Top Small-Cap Catalyst-Driven Idea
UPDATE - Canaccord Genuity Initiates Coverage on MAP Pharmaceuticals (MAPP) with a Buy; Top Small-Cap Catalyst-Driven Idea
View AllRecent Press Releases
View AllRecent SEC Filings
SEC Filing on 02/07/12 at 7:34pm
Form 4 MAP Pharmaceuticals, For: Feb 06 Filed by: GIANAKAKOS ANASTASIOS
Form 4 MAP Pharmaceuticals, For: Feb 06 Filed by: GIANAKAKOS ANASTASIOS